High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.
Kongtim P, Qazilbash MH, Shah JJ, Hamdi A, Shah N, Bashir Q, Wang M, Champlin R, Manasanch EE, Weber D, Orlowski RZ, Parmar S.
Kongtim P, et al. Among authors: weber d.
Bone Marrow Transplant. 2015 May;50(5):668-72. doi: 10.1038/bmt.2015.21. Epub 2015 Mar 2.
Bone Marrow Transplant. 2015.
PMID: 25730192
Clinical Trial.